T-cell skin lymphomas are more common than B-cell skin lymphomas. Cutaneous T-cell lymphoma (CTCL) occurs when a mutation causes the cell to divide too quickly and stay alive too long. The ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

Citius Oncology, Inc. ("Citius Oncology" or the "Company") , a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported ...

See a doctor who has experience with it. You’ll find dermatologists who have experience with cutaneous T-cell lymphoma at Find a Dermatologist. Click on "Filters". Select "Any condition" and choose ...

T-cell skin lymphomas are more common than B-cell skin lymphomas. T-Cell Skin Lymphoma Cutaneous T-cell lymphoma (CTCL) occurs when a mutation causes the cell to divide too quickly and stay alive too ...

The rate of skin lymphomas has been rising over the past few decades ... Chapter 104: Cutaneous T-cell lymphoma and cutaneous B-cell lymphoma. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, ...

EBV+ diffuse large B-cell lymphomas, and mastocytosis. In the context of skin lymphomagenesis, a type 2 immune profile is typical of mycosis fungoides and Sézary syndrome, the most frequent subtypes ...

The phase 3 FLASH (NCT02448381) study evaluating SGX301 (HyBryte) has shown promising results, with over 70% of patients with early-stage cutaneous T-cell lymphoma (CTCL ... is topically applied to ...